Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma

Figure 2

AIs suppress growth of advanced lesions in lung tumors in Kras G12D-LSL mice. As described in Figure 1, KrasG12D-LSL tumor bearing mice were treated for 8 wks with AIs. Treatments started at 14 wks post administration of Adeno-Cre. At the end of study, all the lung tissues were isolated from the recipients and were analyzed using H&E staining. Images are the representative of each treatment.

Back to article page